BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8245630)

  • 41. [Plasma level of activated factor IX-antithrombin III complex in hypercoagulable state].
    Sugiura I; Takahashi I; Kagami K; Takamatsu J
    Rinsho Byori; 1990 Jul; Suppl 86():149-57. PubMed ID: 2232236
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of partial thromboplastin time and thrombin time in the diagnosis of disseminated intravascular coagulation].
    Frick U; Frick G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):879-81. PubMed ID: 75159
    [No Abstract]   [Full Text] [Related]  

  • 43. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
    Okajima K; Sakamoto Y; Uchiba M
    Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical application of laboratory diagnosis: leukemia and DIC].
    Deguchi K; Zhao LJ; Shirakawa S
    Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
    Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
    Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
    Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
    Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders.
    Takahashi H; Tatewaki W; Wada K; Hanano M; Shibata A
    Am J Hematol; 1990 Feb; 33(2):90-5. PubMed ID: 1689102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypercoagulability and DIC in high-risk infants.
    Suzuki S; Morishita S
    Semin Thromb Hemost; 1998; 24(5):463-6. PubMed ID: 9834014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
    Humphries JE
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):8-16; discussion 17-8. PubMed ID: 8821205
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies on the role of leukocytes in the activation of intravascular coagulation in septicemia].
    Okajima K; Uchiba M; Okabe H; Takatsuki K
    Rinsho Byori; 1990 Jul; 38(7):799-805. PubMed ID: 2205743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of antithrombin-III activity as a coindicator of disseminated intravascular coagulation in cats with induced feline infectious peritonitis virus infection.
    Boudreaux MK; Weiss RC; Cox N; Spano JS
    Am J Vet Res; 1989 Nov; 50(11):1910-3. PubMed ID: 2559630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombin-antithrombin III complexes in the diagnosis of consumption coagulopathy.
    Sureda A; García Avello A; García Frade J; Carmen Torrado MC
    Am J Hematol; 1991 Jan; 36(1):74-6. PubMed ID: 2006932
    [No Abstract]   [Full Text] [Related]  

  • 57. Pathogenesis of disseminated intravascular coagulation.
    Larrieu MJ
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):321-4. PubMed ID: 515795
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical test for early diagnosis of thrombosis].
    Wada H; Sakane Y
    Nihon Naika Gakkai Zasshi; 1997 Jun; 86(6):911-4. PubMed ID: 9340356
    [No Abstract]   [Full Text] [Related]  

  • 59. [A new advance in theory of blood coagulation and fibrinolysis and its practical application].
    Matsuno K; Araki K
    Rinsho Byori; 1991 Feb; 39(2):179-84. PubMed ID: 1904112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.